Use of snake venom fractions in the coagulation laboratory

被引:20
作者
Marsh, NA [1 ]
机构
[1] Queensland Univ Technol, Sch Life Sci, Res Concentrat Biomed Sci, Brisbane, Qld 4001, Australia
关键词
snake venom toxins; haemostasis; coagulation assays; clinical applications;
D O I
10.1097/00001721-199807000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Snake venom toxins are now regularly used in the coagulation laboratory for assaying haemostatic parameters and as coagulation reagents. Snake venom thrombin-like enzymes (SVTLE) are used for fibrinogen and fibrinogen breakdown product assay as well as detecting dysfibrinogenaemias. Significantly, because SVTLE are not inhibited by heparin, they can be used for defibrinating samples that contain the anticoagulant before assay of haemostatic variables. Prothrombin activators are found in many snake venoms and are used in prothrombin assays, for studying dysprothrombinaemias and preparing meizothrombin and non-enzymic prothrombin. Russell's viper (Daboia russelli) venom (RVV) contains a number of compounds useful in the assay of factors V, VII, X, platelet factor 3 and lupus anticoagulants. Activators from the taipan, Australian brown snake and saw-scaled viper have been used to assay lupus anticoagulants. Protein C and activated protein C resistance can be measured by means of RW and Protac(R), a fast acting inhibitor from Southern copperhead snake venom and von Willebrand factor can be studied with Botrocetin(R) from Bothrops jararaca venom. Finally, phospholipase A(2) enzymes and the disintegrins, a family of Arg-Gly-Asp (RGD)-containing proteins found in snake venoms, show great potential for the study of haemostasis including, notably, platelet glycoprotein receptors GPIIb/IIIa and Ib. (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:395 / 404
页数:10
相关论文
共 119 条
[1]  
BACHMANN F, 1958, THROMB DIATH HAEMOST, V2, P24
[2]   Novel anti-platelet aggregation polypeptides from Vipera lebetina venom: Isolation and characterization [J].
Barbouche, R ;
Marrakchi, N ;
Mansuelle, P ;
Krifi, M ;
Fenouillet, E ;
Rochat, H ;
ElAyeb, M .
FEBS LETTERS, 1996, 392 (01) :6-10
[3]   Defibrinogenating enzymes [J].
Bell, WR .
DRUGS, 1997, 54 (Suppl 3) :18-30
[4]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[5]  
BLOOM AL, 1991, THROMB HAEMOSTASIS, V66, P166
[6]  
BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
[7]  
Brandt JT, 1995, THROMB HAEMOSTASIS, V74, P1597
[8]  
BRINKHOUS KM, 1988, HEMOSTASIS ANIMAL VE, P377
[9]  
CANOSO RT, 1979, GASTROENTEROLOGY, V76, P540
[10]  
Carr ME, 1996, THROMB HAEMOSTASIS, V75, P674